Dark

Check out our Level2View

OLK
Olink Holding AB (publ)
stock NASDAQ

Inactive

Jul 9, 2024

26.08USD+0.308%(+0.08)1,890,290

Pre-market

0.00USD-100.000%(-26.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 20, 2022

08:10AM EST Olink Holding Announces Sequanta Technologies Will Use Olink Explore 3072 To Analyze 1,000 Patient Samples From A New Cohort Study In China Benzinga

08:00AM EST Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, will use Olink Explore 3072 to analyze 1,000 patient samples from a new cohort study in China. GlobeNewswire Inc

Jan 10, 2022

02:31PM EST Mid-Afternoon Market Update: Dow Tumbles 250 Points; Zynga Shares Spike Higher Benzinga

08:20AM EST Olink Sees Q4 Sales $43.2M-$43.7M, Sees FY21 Sales $94.5M-$95M Benzinga

08:00AM EST Olink Holding AB (publ) (Olink) (Nasdaq: OLK) today announced preliminary unaudited revenue for the fourth quarter and year ended December 31, 2021, and additional select unaudited performance metrics. GlobeNewswire Inc

Jan 5, 2022

11:07AM EST Stocks That Hit 52-Week Lows On Wednesday Benzinga

Jan 4, 2022

08:00AM EST Olink Holding AB (publ) (Olink) (Nasdaq: OLK), today announced it will be virtually participating in the 40th Annual J.P. Morgan Healthcare Conference. GlobeNewswire Inc

Dec 6, 2021

08:00AM EST Olink Holding AB (publ) (Nasdaq: OLK) today announced a new publication on Olinks PEA technology, providing an invaluable resource to the scientific community. GlobeNewswire Inc

Dec 2, 2021

08:00AM EST Olink Holding AB (publ) (Olink) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of protein biomarkers in the empagliflozin EMPEROR studies, recently entered the data analysis phase. GlobeNewswire Inc

Dec 1, 2021

08:18AM EST Olink Highlights Delivery Of Co.'s Explore 3072 Is Now Starting Benzinga

08:00AM EST Olink Holding AB (publ) (Nasdaq: OLK) today announced that the delivery of OlinkExplore 3072 is now starting, providing customers with access to its expanded library of ~3000 carefully curated and validated assays that together cover of all major biological pathways. GlobeNewswire Inc

Nov 29, 2021

09:00AM EST Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the winner of the young researchers award, Novelties in Biomarkers, Melissa Amrein at the University Hospital of Basel, Switzerland at the Biomarkers of the Future conference in Paris, France. GlobeNewswire Inc

Nov 23, 2021

08:00AM EST Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now starting the delivery ofOlinkSignature Q100, facilitating hands-on access for researchers to Olink technology with a new benchtop system dedicated to multiplex protein biomarker measurement. GlobeNewswire Inc

Nov 11, 2021

08:00AM EST Psomagen, Inc. is partnering with Olink Proteomics, enabling GlobeNewswire Inc

04:55AM EST SVB Leerink Maintains Outperform on Olink Holding, Lowers Price Target to $40 Benzinga

Nov 10, 2021

07:31AM EST Olink Holding Q3 EPS $(0.05), Inline, Sales $20.00M Up From $11.00M YoY; Sees FY21 Sales $90M-$92M Benzinga

07:00AM EST Olink Holding AB (publ) (Olink) (Nasdaq: OLK) today announced its financial results for the third quarter of 2021. GlobeNewswire Inc

04:09AM EST Earnings Scheduled For November 10, 2021 Benzinga

Nov 5, 2021

07:00AM EDT Olink Holding AB (publ) (Olink) (Nasdaq: OLK), today announced that it will be participating in two investor events in November. GlobeNewswire Inc

Oct 20, 2021

08:00AM EDT Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, today announced that it will release financial results for the third quarter of 2021 before the market open on Wednesday, November 10, 2021. Company management will host a conference call to discuss financial results at 8:00 a.m. ET. GlobeNewswire Inc

Sep 1, 2021

07:00AM EDT Olink Holding AB (publ) (Olink) (Nasdaq: OLK), today announced that Jon Heimer, CEO, and Oskar Hjelm, CFO, will participate in the following virtual investor conferences: GlobeNewswire Inc

Aug 31, 2021

07:00AM EDT CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies. GlobeNewswire Inc

Aug 12, 2021

08:03AM EDT Morgan Stanley Maintains Equal-Weight on Olink Holding, Lowers Price Target to $36 Benzinga

Aug 11, 2021

09:06AM EDT Earnings Scheduled For August 11, 2021 Benzinga

07:34AM EDT Olink Reaffirms FY21 Sales Guidance Of $90M-$92M vs $91.77M Est. Benzinga

07:32AM EDT Olink Holding Q2 EPS $(0.09) Misses $(0.07) Estimate, Sales $17.69M Beat $16.40M Estimate Benzinga

07:23AM EDT Olink Q2 Net Loss $10.6 Mln Vs Loss $2.0 Mln Last Year RTTNews

07:00AM EDT Olink Holding AB (publ) (Olink) (Nasdaq: OLK) today announced its financial results for the second quarter of 2021. GlobeNewswire Inc

04:27AM EDT Earnings Scheduled For August 11, 2021 Benzinga

Jul 21, 2021

07:00AM EDT Olink Holding AB (publ) (Nasdaq: OLK) today announced that the UK Biobank Pharma Proteomics Project (UKB-PPP Consortium) has decided to expand the ongoing proteomics study of 53,000 participants to the new Olink Explore 3072 platform, providing access to Olinks expanded library of approximately 3,000 carefully curated and validated assays. GlobeNewswire Inc

Jul 14, 2021

11:05PM EDT Olink Announces Pricing Of Public Offering Of 7.50 Mln ADSs By Selling Shareholders At $31.00/ADS RTTNews

10:47PM EDT Olink Holding AB (publ) Announces Pricing of Public Offering of GlobeNewswire Inc

Jul 13, 2021

08:07AM EDT Olink Holding Says Enters Into Agreement With deCODE Genetics For Early Access To The Olink Explore 3072 Platform Benzinga

Jul 12, 2021

04:33PM EDT Olink Holding AB (publ) (Olink) (Nasdaq: OLK) today announced preliminary unaudited revenue and net income (loss) for the second quarter ended June 30, 2021. GlobeNewswire Inc

04:32PM EDT Olink Holding AB (publ) Launches Public Offering of American GlobeNewswire Inc

04:32PM EDT Olink Sees Prelim. Q2 Sales $17.3M-$17.7M vs $16.4M Est. Benzinga

04:31PM EDT Olink Holding Announces 7M ADS Public Offering Of American Depositary Shares By Selling Shareholders Benzinga

Jun 23, 2021

07:00AM EDT Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is taking orders for Olink Explore 3072, providing customers with access to its expanded library of ~3000 carefully curated and validated assays. GlobeNewswire Inc

Jun 15, 2021

09:02AM EDT Olink Announces SCALLOP Consortium Is Launching Clinical Trial Arm To 'bring together actors working on proteomic profiling in clinical trials' Benzinga

09:00AM EDT Olink: SCALLOP launches clinical trial arm to uncover next level GlobeNewswire Inc

Jun 2, 2021

07:00AM EDT Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink Signature Q100, to allow more researchers access to Olink technology and high-quality proteomics data. Olink Signature Q100 is an affordable new benchtop system designed for readout of Olink Target and Olink Focus protein biomarker panels. GlobeNewswire Inc

May 25, 2021

05:00PM EDT Olink Holding AB (publ) (Olink) (Nasdaq: OLK) today announced that it will be participating in the Goldman Sachs 42nd Annual Global Healthcare Conference. GlobeNewswire Inc

May 21, 2021

07:54AM EDT Morgan Stanley Maintains Equal-Weight on Olink Holding, Lowers Price Target to $38 Benzinga

May 20, 2021

07:16AM EDT Olink Holding Sees FY21 Sales $90M-$92M Benzinga

07:15AM EDT Olink Holding Q1 Sales $13.60M Up From $8.00M YoY Benzinga

07:00AM EDT Olink Holding AB (publ) (Olink) (Nasdaq: OLK) today announced its financial results for the first quarter of 2021. GlobeNewswire Inc

04:08AM EDT Earnings Scheduled For May 20, 2021 Benzinga

May 4, 2021

08:15AM EDT Olink Announces First Core Lab Running Co's Explore Platform In Europe Benzinga

08:00AM EDT Olink Holding AB (publ) (Nasdaq: OLK) today announced that its Olink Explore 1536/384 platform is now available to researchers in Europe through the SciLifeLab National Genomics Infrastructure (NGI) and the Affinity Proteomics Uppsala unit at SciLifeLab Clinical and Immunological platform (APU) by their combined capability SciLifeLab Explore lab. GlobeNewswire Inc

Apr 29, 2021

08:30AM EDT Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, today announced that it will release financial results for the first quarter of 2021 before the market open on Thursday, May 20, 2021. Company management will host a conference call to discuss financial results at 8:00 a.m. ET. GlobeNewswire Inc

Apr 19, 2021

10:16AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2021 Benzinga

08:13AM EDT BTIG Initiates Coverage On Olink Holding with Buy Rating, Announces Price Target of $44 Benzinga

07:48AM EDT Goldman Sachs Initiates Coverage On Olink Holding with Neutral Rating, Announces Price Target of $42 Benzinga

07:46AM EDT Morgan Stanley Initiates Coverage On Olink Holding with Equal-Weight Rating, Announces Price Target of $40 Benzinga

07:14AM EDT SVB Leerink Initiates Coverage On Olink Holding with Outperform Rating, Announces Price Target of $50 Benzinga

Mar 25, 2021

01:07PM EDT Olink Shares Open For Trade At $30.10; IPO Priced At $20/Share Benzinga

12:21PM EDT Olink Shares Indicated $28 Benzinga

12:21PM EDT Olink Shares Indicating $28; IPO Priced At $20/Share Benzinga

09:21AM EDT Olink Shares Will Open For Quote At 11:25 a.m. EDT, Expected To Open For Trade After 11:35 a.m. EDT; IPO Priced At $20/Share Benzinga

Mar 24, 2021

10:25PM EDT Olink Holding Prices IPO Of 17.65 Mln ADSs At $20.00/ADS RTTNews

10:00PM EDT Olink Holding AB (publ) Announces Pricing of Initial Public Offering GlobeNewswire Inc

Share